BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34703240)

  • 1. Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.
    Yilmaz B; Somay E; Selek U; Topkan E
    Ther Clin Risk Manag; 2021; 17():1113-1121. PubMed ID: 34703240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy.
    Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
    BMC Oral Health; 2023 Apr; 23(1):231. PubMed ID: 37081475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pretreatment systemic immune-inflammation index values are associated with diminished short-term success after temporomandibular joint arthrocentesis procedure.
    Somay E; Yilmaz B
    BMC Oral Health; 2021 Oct; 21(1):531. PubMed ID: 34654426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worth of pan-immune-inflammation value in trismus prediction after concurrent chemoradiotherapy for nasopharyngeal carcinomas.
    Somay E; Yilmaz B; Topkan E; Ozdemir BS; Ozturk D; Besen AA; Mertsoylu H; Selek U
    Int J Biol Markers; 2024 Mar; 39(1):80-88. PubMed ID: 38192114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Pretreatment Systemic Immune-Inflammation Index in Glioblastoma Multiforme Patients Undergoing Postneurosurgical Radiotherapy Plus Concurrent and Adjuvant Temozolomide.
    Topkan E; Besen AA; Ozdemir Y; Kucuk A; Mertsoylu H; Pehlivan B; Selek U
    Mediators Inflamm; 2020; 2020():4392189. PubMed ID: 32565725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Teeth Extraction after Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Cancer Patients Using the Novel GLUCAR Index.
    Somay E; Topkan E; Yilmaz B; Besen AA; Mertsoylu H; Selek U
    Diagnostics (Basel); 2023 Dec; 13(23):. PubMed ID: 38066835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
    Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
    J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of pre-chemoradiotherapy Pan-Immune-Inflammation-Value for predicting the osteoradionecrosis rates in locally advanced nasopharyngeal cancers.
    Yilmaz B; Somay E; Topkan E; Kucuk A; Pehlivan B; Selek U
    Strahlenther Onkol; 2023 Oct; 199(10):910-921. PubMed ID: 37566126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Pre-Chemoradiotherapy Total Masseter Muscle Volume as a Novel Predictor of Radiation-Induced Trismus in Locally Advanced Nasopharyngeal Carcinoma Patients.
    Somay E; Topkan E; Pehlivan UA; Yilmaz B; Besen AA; Mertsoylu H; Pehlivan B; Selek U
    Tomography; 2024 Jan; 10(1):79-89. PubMed ID: 38250953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tooth extractions prior to chemoradiation or bioradiation are associated with weight loss during treatment for locally advanced oropharyngeal cancer.
    Buurman DJM; Willemsen ACH; Speksnijder CM; Baijens LWJ; Hoeben A; Hoebers FJP; Kessler P; Schols AMWJ
    Support Care Cancer; 2022 Jun; 30(6):5329-5338. PubMed ID: 35278135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valero's host index is useful in predicting radiation-induced trismus and osteoradionecrosis of the jaw risks in locally advanced nasopharyngeal carcinoma patients.
    Topkan E; Somay E; Yilmaz B; Pehlivan B; Selek U
    BMC Cancer; 2023 Jul; 23(1):651. PubMed ID: 37438683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas.
    Topkan E; Selek U; Kucuk A; Pehlivan B
    J Inflamm Res; 2022; 15():5413-5423. PubMed ID: 36158517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Advanced Lung Cancer Inflammation Index Predicts Poor Prognosis in Locally Advanced Nasopharyngeal Carcinoma Patients Treated with Definitive Concurrent Chemoradiotherapy.
    Topkan E; Ozdemir Y; Kucuk A; Guler OC; Sezer A; Besen AA; Mertsoylu H; Senyurek S; Kilic Durankus N; Bolukbasi Y; Selek U; Pehlivan B
    J Oncol; 2020; 2020():3127275. PubMed ID: 33082783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic immune-inflammation index changes predict outcome in stage III non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
    Huang T; Zhang H; Zhao Y; Li Y; Wang G; Zhang Y; Guo D; Ji S; Sun Z
    Future Oncol; 2021 Jun; 17(17):2141-2149. PubMed ID: 33635094
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
    Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T
    Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
    Cheong C; Shin JS; Suh KW
    World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-chemoradiotherapy low hemoglobin levels indicate increased osteoradionecrosis risk in locally advanced nasopharyngeal cancer patients.
    Yilmaz B; Somay E; Topkan E; Pehlivan B; Selek U
    Eur Arch Otorhinolaryngol; 2023 May; 280(5):2575-2584. PubMed ID: 36749372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
    He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
    Front Oncol; 2022; 12():829689. PubMed ID: 35296020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.